InterventionsHuman trial

GLP-1 Receptor Agonist Treatment Promotes IL6-Dependent Activation of Brown Adipogenesis Program and Glucose Uptake in Adipose Tissue of Insulin-Resistant Humans

ADA Scientific Sessions 2026 Abstract

The paper

GUTIERREZ AD, GAO Z, WANG H et al.

ADA Scientific Sessions 2026 Abstract · 5 Jun 2026

Presented at ADA Scientific Sessions 2026 · Late-breaking 3057-LB

doi.org/10.2337/db26-3057-lb

Semaglutide may protect kidneys by reducing vascular resistance
Nature Medicine · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
GLP-1 receptor agonists link to lower stroke and Alzheimer risk
Neurology Genetics · 4 Oct 2026